Your browser doesn't support javascript.
loading
The vascular function effects of adding exenatide or meal insulin to basal insulin therapy in early type 2 diabetes.
Retnakaran, Ravi; Pu, Jiajie; Ye, Chang; Emery, Alexandra; Kramer, Caroline K; Zinman, Bernard.
  • Retnakaran R; Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Canada. Ravi.Retnakaran@sinaihealth.ca.
  • Pu J; Division of Endocrinology, University of Toronto, 60 Murray Street, Suite L5-025, Toronto, ON, M5T 3L9, Canada. Ravi.Retnakaran@sinaihealth.ca.
  • Ye C; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada. Ravi.Retnakaran@sinaihealth.ca.
  • Emery A; Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Canada.
  • Kramer CK; Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Canada.
  • Zinman B; Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Canada.
Cardiovasc Diabetol ; 22(1): 50, 2023 03 09.
Article en En | MEDLINE | ID: mdl-36894921
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adult / Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adult / Humans Idioma: En Año: 2023 Tipo del documento: Article